The immunotherapy Foundation supports research and programming to treat, and ultimately eradicate, HPV-driven cancers. IF works directly with world-class researchers to accelerate the discovery and development of new and improved immunotherapies for patients, by translating multiple research projects into the clinical setting and creating a robust portfolio of preclinical immunotherapies and award-winning research at the University of California.
You are currently on Concordia’s official website: www.concordia.net
We have identified a fraudulent website operating under
www.theconcordiasummit.org
that is impersonating Concordia and using our brand, language, and images without authorization. This site is not affiliated with Concordia. If you have shared personal or payment information with that website, please contact us immediately at enquiries@concordia.net. We are actively working to have the site removed.